Albuterol inhaler side effects
Pro Research Analysisby 
Searched over 200M research papers
Albuterol Inhaler Side Effects: A Comprehensive Overview
Cardiovascular Side Effects of Albuterol Inhalers
Albuterol, a beta2-adrenergic receptor agonist, is widely used for the treatment of asthma due to its bronchodilatory effects. However, its use is associated with several cardiovascular side effects. Studies have shown that inhalation of albuterol can significantly increase heart rate (HR) and systolic blood pressure (BP) while decreasing diastolic BP . These effects are indicative of systemic beta-adrenergic stimulation, which can occur as early as five minutes after inhalation and peak within 30 minutes . Additionally, high doses of albuterol have been linked to a greater increase in the Q-Tc interval and a decrease in serum potassium levels, which can lead to cardiac arrhythmias .
Metabolic Side Effects of Albuterol Inhalers
Albuterol also has notable metabolic side effects. It can cause a decrease in plasma potassium, phosphate, calcium, and magnesium levels, while increasing plasma glucose, insulin, renin, lactate, and ketone levels . These metabolic changes are dose-related and more pronounced with parenteral administration compared to aerosol administration, which results in lower systemic concentrations . Despite these effects, mouth rinsing and gargling after inhalation do not significantly reduce the magnitude of these side effects .
Respiratory and Muscular Side Effects
While albuterol is effective in bronchodilation, it can also cause skeletal muscle tremors, which are a common side effect of beta2-agonists . In a study comparing albuterol with terbutaline, both drugs caused significant bronchodilation with minimal effects on blood pressure and heart rate, and reported side effects were minimal . However, higher doses of albuterol can lead to increased heart rate, tremor amplitude, and supraventricular ectopic beats, along with a dose-related fall in oxygen saturation .
Comparison with Other Beta-Agonists
When compared to other beta-agonists like fenoterol and isoetharine, albuterol has shown a relatively safer cardiovascular profile. For instance, fenoterol was associated with a greater decrease in serum potassium levels and a more significant increase in the Q-Tc interval compared to albuterol . Similarly, isoetharine caused more side effects than albuterol, despite having a greater immediate effect on bronchodilation .
Long-Term Safety and Tolerability
Long-term studies have evaluated the safety of albuterol multidose dry powder inhalers (MDPI) in patients with persistent asthma. These studies found that adverse events were more common with placebo than with albuterol MDPI, with the most frequent being upper respiratory tract infections, nasopharyngitis, and headaches . The safety profile of albuterol MDPI was consistent with the well-characterized profile of albuterol, showing minimal side effects over extended use .
Conclusion
Albuterol inhalers are effective in managing asthma symptoms but come with a range of side effects, particularly cardiovascular and metabolic. While these side effects are generally dose-related and more pronounced with higher doses, they are relatively minimal with standard aerosol administration. Long-term use of albuterol MDPI appears to be safe and well-tolerated, making it a viable option for patients with persistent asthma. However, patients should be monitored for potential side effects, especially when using higher doses or in combination with other medications.
Sources and full results
Most relevant research papers on this topic